Compounds > sulfamethoxypyridazine
Page last updated: 2024-11-04

sulfamethoxypyridazine and Anemia, Hemolytic, Congenital

sulfamethoxypyridazine has been researched along with Anemia, Hemolytic, Congenital in 1 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Anemia, Hemolytic, Congenital: Hemolytic anemia due to various intrinsic defects of the erythrocyte.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SALVIOLI, GP1

Other Studies

1 other study available for sulfamethoxypyridazine and Anemia, Hemolytic, Congenital

ArticleYear
[ON A CASE OF HEMOLYTIC ANEMIA DUE TO SULFAMETHOXYPYRIDAZINE IN A SUBJECT WITH ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY].
    La Clinica pediatrica, 1963, Volume: 45

    Topics: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Erythrocytes; Favism; Genetics, Medical; G

1963